NEW YORK, May 22 – Softbank Finance of Japan and Scientia Health Group, an American incubator for biotechnology ideas, will launch Scientia Japan, which will support genomics firms in Japan, Reuters reported from Tokyo on Tuesday.

"I'm very proud to announce this. We're entering into the world of human genomics," Reuters cited Yoshitaka Kitao, president of Softbank Finance, as saying at a news conference.

Japan has only some 60 genome-related companies, Kitao reportedly said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.